Subscribe to RSS
DOI: 10.1055/s-0044-1782606
Research on the Mechanism of Si Xian Decoction in Treating Acute Leukemia Based on Network Pharmacology and Molecular Docking Technology
Funding This work was supported by the Key Research Project of Henan Province Traditional Chinese Medicine Science (2021ZY1050, 2024ZY1010).
Abstract
Objective Our objective was to investigate the mechanism of action of the Si Xian Decoction (SXD) in treating acute leukemia (AL) using network pharmacology and molecular docking techniques.
Methods The chemical components of the four medicinal herbs of Shengdi (Rehmanniae Radix), Baimaogen (Imperatae Rhizoma), Xiaoji (Cirsii Herba), and Pugongying (Taraxaci Herba) in the SXD were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine (BATMAN-TCM), and Encyclopedia of Traditional Chinese Medicine (ETCM). A natural active chemical component dataset for the SXD was established. Human Gene Database (Gencards), Database of Gene-Disease Associations (DisGeNET), Database for Drug and Drug Target Information (DrugBank), and Human Disease Database (MalaCards) were searched to obtain AL-related targets and to establish a disease target database. After obtaining the intersection targets of drugs and diseases, a Venn diagram of the common targets was drawn online. A drug-disease protein interaction network was constructed using the String 11.5 platform, and a “drug-disease-target-signal pathway” network was built using Cytoscape 3.8.2 software to obtain relevant target network topology parameters.
Results By searching the TCMSP, BATMAN-TCM, and ETCM databases, 30 active components of the SXD and 677 related targets were obtained. From Gencards, DrugBank, MalaCards, and DisGeNET databases, 12,110 potential AL disease targets were obtained. Using the ClusterProfiler package of the R4.2.2 platform, 1,011 entries of gene ontology information were enriched, including 467 biological process entries, 236 molecular function entries, and 308 cellular component entries. Additionally, 220 enriched Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathways were obtained, mainly involving chemical carcinogen receptor activation, lipid and atherosclerosis, fluid shear stress and atherosclerosis, prostate cancer, and the role of the advanced glycation end products-receptor for advanced glycation end products (AGE-RAGE) signaling pathway in diabetic complications. Network topology analysis revealed that the main active components of SXD treating AL include γ-aminobutyric acid, adenosine, quercetin, scopolamine, and taraxasterol.
Conclusion The treatment of AL with the SXD is a process of multicomponent, multitarget, and multisignal pathway coordination. Network pharmacology provides a solid research basis for elucidating the mechanism of action of SXD in the treatment of AL.
CRediT Authorship Contribution Statement
Zihan Jiang: Date curation and formal analysis. Man Zhang: Methodology and validation. Jiayuan Guo: project administration and visualization. Jiayuan Guo: Resources. Wenqing Liu: Software. Jue Guo: Supervision. Qiuling Ma: Conceptualization, funding acquisition, writing—original draft, and writing—review & editing.
Publication History
Received: 06 December 2023
Accepted: 20 January 2024
Article published online:
30 March 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Koedijk JB, van der Werf I, Calkoen FG. et al. Paving the way for immunotherapy in pediatric acute myeloid leukemia: current knowledge and the way forward. Cancers (Basel) 2021; 13 (17) 4364
- 2 Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin 2021; 71 (01) 7-33
- 3 Yao CL, Zhang JQ, Li JY, Wei WL, Wu SF, Guo DA. Traditional Chinese medicine (TCM) as a source of new anticancer drugs. Nat Prod Rep 2021; 38 (09) 1618-1633
- 4 Hu J, Liu YF, Wu CF. et al. Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A 2009; 106 (09) 3342-3347
- 5 Wang ZM, Du YL, Wang J. Sun Yimin's experience in treating acute leukemia with fresh herbs. Beijing J Tradit Chin Med 2008; 27 (01) 51-52
- 6 Tao JL, Zhang HR. Analysis of the application of fresh herbs in warm diseases. Lishizhen Med Mater Med Res 2014; 25 (03) 689-690
- 7 Fu YL, Chen T. [Research of traditional Chinese medicine in the treatment of leukemia: current status]. J Chin Integr Med 2008; 6 (08) 867-872
- 8 Zhang J, Kang L, Li XM. et al. The effect of Si Xian decoction juice on WEHI-3 mice model of acute myelomonocytic leukemia. J Chongqing Univ of Technol 2021; 35 (07) 209-215 (Nat Sci)
- 9 Piñero J, Bravo À, Queralt-Rosinach N. et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res 2017; 45 (D1): D833-D839
- 10 Chen WL, Wang JH, Zhao AH. et al. A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value. Blood 2014; 124 (10) 1645-1654
- 11 Huang LM. Thinking on Chinese medicine diagnosis and treatment of fever in acute leukemia. Shanghai J Tradit Chin Med 2003; 49 (04) 11-13
- 12 Chiu TH, Tsai SJ, Wu TY, Fu SC, Hwang YT. Improvement in antioxidant activity, angiotensin-converting enzyme inhibitory activity and in vitro cellular properties of fermented pepino milk by Lactobacillus strains containing the glutamate decarboxylase gene. J Sci Food Agric 2013; 93 (04) 859-866
- 13 Zhao J, Jia JW, Gao LY. et al. Clinical observation of fresh rehmannia in the treatment of chronic and severe liver syndrome. Liaoning J Tradit Chin Med 2006; 46 (08) 952-953
- 14 Hu K, Miao L, Goodwin TJ, Li J, Liu Q, Huang L. Quercetin remodels the tumor microenvironment to improve the permeation, retention, and antitumor effects of nanoparticles. ACS Nano 2017; 11 (05) 4916-4925
- 15 Chen W, Padilla MT, Xu X. et al. Quercetin inhibits multiple pathways involved in interleukin 6 secretion from human lung fibroblasts and activity in bronchial epithelial cell transformation induced by benzo[a]pyrene diol epoxide. Mol Carcinog 2016; 55 (11) 1858-1866
- 16 Chang JL, Chow JM, Chang JH. et al. Quercetin simultaneously induces G0 /G1 -phase arrest and caspase-mediated crosstalk between apoptosis and autophagy in human leukemia HL-60 cells. Environ Toxicol 2017; 32 (07) 1857-1868
- 17 Nie Q. Purification, sulfation and antioxidant activity of polysaccharides from Cirsium Setosum. Shanxi Normal University; 2014
- 18 Yang BY, Yang CL, Liu Y. Research progress on Cirsium setosum . Chin Tradit Herbal Drugs 2017; 48 (23) 5039-5048
- 19 Ovadje P, Chatterjee S, Griffin C, Tran C, Hamm C, Pandey S. Selective induction of apoptosis through activation of caspase-8 in human leukemia cells (Jurkat) by dandelion root extract. J Ethnopharmacol 2011; 133 (01) 86-91
- 20 Bin Sayeed MS, Ameen SS. Beta-sitosterol: a promising but orphan nutraceutical to fight against cancer. Nutr Cancer 2015; 67 (08) 1214-1220
- 21 Ma CY, Wang YH, Yang M. Pharmacological mechanisms and clinical application of rhizoma imperatae and its extracts. Med Rec 2019; 25 (02) 370-374
- 22 Gonçalves Pereira RC, Gontijo Evangelista FC, Dos Santos Júnior VS. et al. Cytotoxic activity of triterpenoids from Cheiloclinium cognatum branches against chronic and acute leukemia cell lines. Chem Biodivers 2020; 17 (12) e2000773
- 23 Zhao Z, Gao QP, Ju D. Effect of ganoderma triterpenes on human blood monocy tic leukemia cell line THP-1. Clinl Focus 2012; 27 (15) 1325-1328